Literature DB >> 24099530

The influence of pH and hypoxia on tumor metastasis.

Mariam Abaza1, Yunus A Luqmani.   

Abstract

Rapid malignant proliferation, prior to effective tumor neoangiogenesis, creates a microenvironment around solid cancers, which is predominantly hypoxic and characterized by a high interstitial fluid pressure. Presumably as an adaptive response, tumor cells favor metabolic activity with apparently inefficient energy output, and production of intermediates that promote cellular replication, preferentially through anaerobic glycolysis, a phenomenon that persists even in re-established normoxic conditions (anomalously referred to as 'aerobic glycolysis'). Extrusion of the consequently excessive accumulation of lactate and protons decreases extracellular pH, leading to a microenvironment considered conducive to promotion of tumor motility, invasion and metastasis, and one that will invariably influence response to drug treatment. This review will critically assess the evidence forming the basis of current understanding of the precise pH conditions in the extracellular tumor matrix, its regulation by cancer cells and relationship with hypoxia, its relevance to malignant progression and its exploitation for therapeutic advantage.

Entities:  

Mesh:

Year:  2013        PMID: 24099530     DOI: 10.1586/14737140.2013.843455

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  11 in total

Review 1.  Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review.

Authors:  Sergio Pérez Regalado; Josefa León; Belén Feriche
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-14       Impact factor: 4.322

Review 2.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

3.  Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.

Authors:  Wei-Ju Huang; Yung-Ming Jeng; Hong-Shiee Lai; Iok-U Fong; Fang-Yu Bonnie Sheu; Po-Lin Lai; Ray-Hwang Yuan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

4.  Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.

Authors:  Jianwen Jiang; Qiuxian Zheng; Weiwei Zhu; Xinhua Chen; Haifeng Lu; Deying Chen; Hua Zhang; Min Shao; Lin Zhou; Shusen Zheng
Journal:  Aging (Albany NY)       Date:  2020-06-01       Impact factor: 5.682

5.  Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway.

Authors:  Ping Zhang; Yang Zhang; Kuikui Liu; Bin Liu; Wenping Xu; Jufang Gao; Lei Ding; Liming Tao
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

6.  Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer.

Authors:  David E Korenchan; Robert Bok; Renuka Sriram; Kristina Liu; Romelyn Delos Santos; Hecong Qin; Iryna Lobach; Natalie Korn; David M Wilson; John Kurhanewicz; Robert R Flavell
Journal:  Oncotarget       Date:  2019-10-22

7.  Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma.

Authors:  Tuo Deng; Qian Ye; Chen Jin; Mingliang Wu; Kaiyu Chen; Jinhuan Yang; Ziyan Chen; XiXiang Yu; Gang Chen; Yi Wang
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

8.  Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.

Authors:  Maitham A Khajah; Sarah Khushaish; Yunus A Luqmani
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

9.  Effects of Environmental pH on the Growth of Gastric Cancer Cells.

Authors:  Wenjie Li; Ying Zhou; Chunyu Shang; Hui Sang; Hong Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-03-09       Impact factor: 2.260

10.  The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells.

Authors:  Chiara Bellio; Celeste DiGloria; David R Spriggs; Rosemary Foster; Whitfield B Growdon; Bo R Rueda
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.